Arbor Biotechnologies Stock

A Biotech Company.

About Arbor Biotechnologies Stock

None

Funding History

June 2017	$12.2M

Press

New RNA CRISPR Tool Normalizes Tau Splicing

Alzforum - Mar, 23 2018

Arbor Biotechnologies Discovers New CRISPR System Utilizing its Discovery Platform

GlobeNewswire (press release) - Mar, 15 2018

Other Companies

Learn More

4D Molecular Therapeutics

4D Molecular Therapeutics’ mission is to design and develop transformative gene therapy products using our proprietary.

7Age (years)

$10.0MTotal Funding

Learn More

Nabi Biopharmaceuticals

Nabi Biopharmaceuticals develops preventive measures and treatments for diseases.

53Age (years)

$10.0MTotal Funding

Learn More

Newlight Technologies

Carbon technology to produce thermoplastics

Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.

11Age (years)

$137MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Arbor Biotechnologies or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.